↓ Skip to main content

Cochrane Database of Systematic Reviews

Antipsychotic medication for challenging behaviour in people with learning disability

Overview of attention for article published in Cochrane database of systematic reviews, July 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

blogs
2 blogs
policy
1 policy source
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
81 Dimensions

Readers on

mendeley
135 Mendeley
citeulike
1 CiteULike
Title
Antipsychotic medication for challenging behaviour in people with learning disability
Published in
Cochrane database of systematic reviews, July 2004
DOI 10.1002/14651858.cd000377.pub2
Pubmed ID
Authors

Jane Brylewski, Lorna Duggan

Abstract

The term 'challenging behaviour', in the absence of psychiatric disorder, encompasses a wide range of behaviours that may be harmful to people or property, may be difficult to manage and may limit access to community facilities. Antipsychotic medications have been used to modify such behaviours in people with learning disability, but there is little evidence to suggest that the benefits outweigh the risks.

Mendeley readers

The data shown below were compiled from readership statistics for 135 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Unknown 133 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 25 19%
Researcher 18 13%
Student > Bachelor 16 12%
Student > Doctoral Student 15 11%
Student > Ph. D. Student 12 9%
Other 24 18%
Unknown 25 19%
Readers by discipline Count As %
Medicine and Dentistry 44 33%
Psychology 24 18%
Nursing and Health Professions 10 7%
Social Sciences 10 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 15 11%
Unknown 28 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 September 2021.
All research outputs
#1,699,666
of 21,094,310 outputs
Outputs from Cochrane database of systematic reviews
#3,933
of 12,079 outputs
Outputs of similar age
#18,734
of 205,166 outputs
Outputs of similar age from Cochrane database of systematic reviews
#71
of 203 outputs
Altmetric has tracked 21,094,310 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,079 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.7. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 205,166 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 203 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.